CAPR

Capricor Therapeutics Inc. Common Stock (CAPR)

Stock · NASDAQ · Health Care

$9.59as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$28.61
Industry
Biotechnology: Pharmaceutical Preparations

About CAPR

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The comp…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
231

Fundamentals

1-day range
$8.9$10.61
Market cap
$243.23M
P/E (trailing)
P/E (forward)
-6.34
EPS (trailing)
$-2.31
Dividend yield
Beta
0.55
Avg. volume
5.83M
Dividend pay date
June 5, 2019
52-week range
$2.96$40.37
Next earnings: November 10, 2026 · EPS estimate $-0.42confirmed

How Capricor Therapeutics Inc. Common Stock Makes Money

Where the revenue actually goes — FY2024 annual results

market-wall.comTotalRevenue$22.27MR&D$50.00M (225%)SG&A$14.87M (67%)CAPR

Source: 10-K filed Mar 26, 2025 · via SEC EDGAR / Finnhub

Forecasts

4 analyst ratings

Buy 0%
Hold 80%
Sell 20%
1-year price forecast
High
$54
+463.1%
Median
$17.5
+82.5%
Low
$2
-79.1%

Capricor Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • CAPR
    Capricor Therapeutics Inc. Common Stock
    $9.59
    ▼ 4.67%
    Market cap $243.23MP/E
    $2.96$40.37
  • MGNX
    MacroGenics Inc. Common Stock
    $4.13
    ▲ 1.23%
    Market cap $242.81MP/E
    $1.29$5.08
  • ADAG
    Adagene Inc. American Depositary Shares
    $3.68
    ▼ 5.64%
    Market cap $239.77MP/E
    $1.3$4.85
  • SLGL
    Sol-Gel Technologies Ltd. Ordinary Shares
    $69.41
    ▼ 4.35%
    Market cap $230.38MP/E
    $21$97.97
  • VRXA
    Veraxa Biotech AG Ordinary Shares
    $1.36
    ▼ 5.56%
    Market cap $258.78MP/E
    $1.32$27.36
  • ALXO
    ALX Oncology Holdings Inc. Common Stock
    $2
    ▼ 2.44%
    Market cap $259.71MP/E
    $0.96$2.66
  • ELDN
    Eledon Pharmaceuticals Inc. Common Stock
    $3.19
    ▼ 3.92%
    Market cap $264.75MP/E
    $1.35$4.6

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
138.7K
Disposed
51.8K
  • Bergmann Anthony · June 24, 2026 · Option Exercise
    400 @ $3.18
  • Bergmann Anthony · June 24, 2026 · Sale
    400 @ $30
  • Krasney Karen · June 24, 2026 · Option Exercise
    400 @ $3.18
  • Krasney Karen · June 24, 2026 · Sale
    400 @ $30
  • Bergmann Anthony · June 22, 2026 · Option Exercise
    500 @ $3.18
  • Bergmann Anthony · June 22, 2026 · Sale
    500 @ $30
  • Krasney Karen · June 22, 2026 · Option Exercise
    500 @ $3.18
  • Krasney Karen · June 22, 2026 · Sale
    500 @ $30
  • Maurer Michael T · May 26, 2026 · Grant
    80.0K
  • Bergmann Anthony · May 18, 2026 · Option Exercise
    3.0K @ $1.39
  • Litvack Frank · May 13, 2026 · Option Exercise
    3.9K @ $1.39
  • Bergmann Anthony · May 1, 2026 · Option Exercise
    25.0K @ $3.18
  • Bergmann Anthony · May 1, 2026 · Sale
    25.0K @ $31.7
  • Krasney Karen · May 1, 2026 · Option Exercise
    25.0K @ $3.18
  • Krasney Karen · May 1, 2026 · Sale
    25.0K @ $31.7

Institutional Ownership

March 31, 2026

Total shares held
37.60M
Total value held
$1.14B
Institutional holders
175
Top holders this quarter
  • Unknown3.82M
  • Unknown3.42M
  • Unknown3.40M
  • Unknown2.18M
  • Unknown2.03M
  • Unknown1.51M
  • Unknown1.44M
  • Unknown1.37M
  • Unknown1.12M
  • Unknown1.03M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.